9D Home Care Pty Ltd

9dhomecare.com.au

9D Homecare is a registered NDIS Service Provided based in Melbourne specialising in providing a discreet quality but full fledge range of Residential and Home Care for all purpose service in accordance with individual demands and necessities.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Cell and Gene Therapy

TUNE THERAPEUTICS LAUNCHES WITH PIONEERING EPIGENOMIC CONTROL PLATFORM TO MASTER GENE NETWORKS, TREAT BROAD RANGE OF DISEASES

Tune Therapeutics | December 03, 2021

news image

Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched today with its powerful and precise genetic tuning platform, TEMPO. This cutting-edge technology dials gene expression up or down to desired levels – with the potential to reverse pathways of cancer, genetic disease, and aging by changing cell fate and function at will. "Genetic medicine is at a tipping point. We now understand that the driving...

Read More

Medical

MINDMED ANNOUNCES THE START OF THE FIRST EVER CLINICAL TRIAL MEASURING AND EVALUATING MDMA AND LSD

MindMed | January 21, 2021

news image

MindMed, a main psychedelic medication biotech organization, reported today the beginning of the principal ever clinical preliminary estimating and assessing MDMA and LSD utilized in mix in the human body. The preliminary will be directed at the University Hospital Basel Liechti Lab, in Basel, Switzerland. If administered in combination with LSD, MDMA may expand positive abstract medication impacts, including positive state of mood and empathy, and lessen the negative feelings and...

Read More

Industrial Impact, Medical

MODERNA AND GENERATION BIO ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP NON-VIRAL GENETIC MEDICINES

Accesswire | March 24, 2023

news image

Moderna, Inc. a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Generation Bio Co. a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that the two companies have entered into a strategic collaboration to combine Moderna's biological and technical expertise with core technologies of Generation Bio's non-viral genetic medicine platform. The collaboration aims to expand the application ...

Read More

ROIVANT PROVIDES UPDATES FOR PIVOTAL BREATHE CLINICAL TRIAL EVALUATING GIMSILUMAB IN COVID-19

Roivant | May 13, 2020

news image

Roivant Sciences today announced several updates for its adaptive, randomized, double-blind, placebo-controlled, multi-center pivotal BREATHE trial evaluating the impact of intravenous (IV) treatment with gimsilumab on mortality in COVID-19 patients with lung injury or ARDS.The independent Data Monitoring Committee (DMC) for BREATHE unanimously recommended that the trial continue after a pre-specified safety assessment evaluating data from the first 10% of randomized subjects after six day...

Read More
news image

Cell and Gene Therapy

TUNE THERAPEUTICS LAUNCHES WITH PIONEERING EPIGENOMIC CONTROL PLATFORM TO MASTER GENE NETWORKS, TREAT BROAD RANGE OF DISEASES

Tune Therapeutics | December 03, 2021

Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched today with its powerful and precise genetic tuning platform, TEMPO. This cutting-edge technology dials gene expression up or down to desired levels – with the potential to reverse pathways of cancer, genetic disease, and aging by changing cell fate and function at will. "Genetic medicine is at a tipping point. We now understand that the driving...

Read More
news image

Medical

MINDMED ANNOUNCES THE START OF THE FIRST EVER CLINICAL TRIAL MEASURING AND EVALUATING MDMA AND LSD

MindMed | January 21, 2021

MindMed, a main psychedelic medication biotech organization, reported today the beginning of the principal ever clinical preliminary estimating and assessing MDMA and LSD utilized in mix in the human body. The preliminary will be directed at the University Hospital Basel Liechti Lab, in Basel, Switzerland. If administered in combination with LSD, MDMA may expand positive abstract medication impacts, including positive state of mood and empathy, and lessen the negative feelings and...

Read More
news image

Industrial Impact, Medical

MODERNA AND GENERATION BIO ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP NON-VIRAL GENETIC MEDICINES

Accesswire | March 24, 2023

Moderna, Inc. a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Generation Bio Co. a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that the two companies have entered into a strategic collaboration to combine Moderna's biological and technical expertise with core technologies of Generation Bio's non-viral genetic medicine platform. The collaboration aims to expand the application ...

Read More
news image

ROIVANT PROVIDES UPDATES FOR PIVOTAL BREATHE CLINICAL TRIAL EVALUATING GIMSILUMAB IN COVID-19

Roivant | May 13, 2020

Roivant Sciences today announced several updates for its adaptive, randomized, double-blind, placebo-controlled, multi-center pivotal BREATHE trial evaluating the impact of intravenous (IV) treatment with gimsilumab on mortality in COVID-19 patients with lung injury or ARDS.The independent Data Monitoring Committee (DMC) for BREATHE unanimously recommended that the trial continue after a pre-specified safety assessment evaluating data from the first 10% of randomized subjects after six day...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us